Ligand Pharmaceuticals (LGND) Other Working Capital Changes (2010 - 2023)
Ligand Pharmaceuticals (LGND) reported Other Working Capital Changes of -$207000.0 for Q1 2026, down 122.62% on a YoY basis from $915000.0 in Q1 2025, and down 104.64% sequentially from $4.5 million in Q4 2025.
Ligand Pharmaceuticals (LGND) Other Working Capital Changes (2010 - 2023) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 11 years of Other Working Capital Changes data on file, last reported at -$207000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 122.62% year-over-year to -$207000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (down 55.24% YoY), and the FY2025 full-year result was $3.9 million, down 17.7% from the prior year.
- Other Working Capital Changes fell to -$207000.0 in Q1 2026, from $4.5 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.1 million in Q2 2020 to a low of -$8.9 million in Q2 2021.
- A 4-year average of -$1.5 million and a median of -$881500.0 in 2020 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 2839.04% in 2024, while the deepest fall reached 9297.26% in 2024.
- Tracing LGND's Other Working Capital Changes over 5 years: stood at -$1.2 million in 2022, then jumped by 144.22% to $513000.0 in 2023, then surged by 796.69% to $4.6 million in 2024, then fell by 2.93% to $4.5 million in 2025, then tumbled by 104.64% to -$207000.0 in 2026.
- Business Quant data shows LGND's Other Working Capital Changes at -$207000.0 in Q1 2026, $4.5 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -98,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Sep 30, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 199,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | -2.45 Mn |
| Mar 31, 2022 | -2.45 Mn |
| Mar 31, 2022 | -2.45 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Jun 30, 2021 | -8.91 Mn |
| Jun 30, 2021 | -8.91 Mn |
| Jun 30, 2021 | -8.91 Mn |
| Mar 31, 2021 | -5.70 Mn |
| Mar 31, 2021 | -5.70 Mn |